Suppr超能文献

可复性盆腔器官脱垂和阴道癌放疗期间使用子宫托:一例病例报告及文献综述

Using a pessary during radiotherapy in reducible pelvic organ prolapse and vaginal cancer: a case report and review of the literature.

作者信息

Gultekin Melis, Esen Caglayan Selenge Beduk, Akgor Utku, Salman Mehmet Coskun, Tuncel Murat, Ozmen Mustafa, Yildiz Ferah

机构信息

Department of Radiation Oncology, Hacettepe University Medical School, Ankara, Turkey.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

出版信息

J Contemp Brachytherapy. 2020 Apr;12(2):175-180. doi: 10.5114/jcb.2020.92997. Epub 2020 Feb 11.

Abstract

PURPOSE

Primary vaginal cancer and pelvic organ prolapse (POP) combination is extremely rare. Although definitive chemoradiotherapy (CRT) and brachytherapy (BT) is the standard treatment for advanced stage primary vaginal cancer, there is a limited data about the treatment of primary vaginal cancer combined with POP due to its rarity. In addition, radiotherapy (RT) process may be difficult in these cases and often result in more toxicity.

CASE PRESENTATION

In this case report, we present a 77-year-old woman with a diagnosis of primary vaginal cancer associated with POP, who was treated with definitive CRT using a pessary to restore vaginal anatomy for optimal radiation. Following CRT, complete response was observed and vaginal cuff BT was performed. The patient tolerated the treatment very well and is still alive without disease at 10-months follow-up.

CONCLUSIONS

Combined primary vaginal cancer and POP is an extremely rare clinical entity, with only a few cases reported in the literature. When applying CRT in these cases, critical organ doses may be higher than expected due to the downward descent of the pelvic organs. Especially in elderly patients, a pessary can be used as a non-surgical procedure to restore the anatomy for symptom relief during definitive CRT. Additionally, it allows tumors to be targeted more precisely.

摘要

目的

原发性阴道癌与盆腔器官脱垂(POP)合并极为罕见。尽管根治性放化疗(CRT)和近距离放疗(BT)是晚期原发性阴道癌的标准治疗方法,但由于其罕见性,关于原发性阴道癌合并POP的治疗数据有限。此外,在这些病例中放疗(RT)过程可能困难,且常导致更多毒性。

病例报告

在本病例报告中,我们介绍了一名77岁诊断为原发性阴道癌合并POP的女性,她接受了根治性CRT治疗,使用子宫托恢复阴道解剖结构以实现最佳放疗。CRT后观察到完全缓解,并进行了阴道残端BT。患者对治疗耐受良好,在10个月的随访中无疾病存活。

结论

原发性阴道癌与POP合并是一种极为罕见的临床实体,文献中仅有少数病例报道。在这些病例中应用CRT时,由于盆腔器官向下移位,关键器官剂量可能高于预期。特别是在老年患者中,子宫托可作为一种非手术方法,在根治性CRT期间恢复解剖结构以缓解症状。此外,它还能更精确地靶向肿瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09d/7207234/454df296eb3a/JCB-12-39879-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验